Prednisolone Tablets: Uses, Dosing, and Safety

Prednisolone is a synthetic corticosteroid taken by mouth to reduce inflammation and suppress an excessive immune response. Prescribers use it for many inflammatory, allergic, and autoimmune conditions when treatment needs to act throughout the body. The tablets can provide effective short-term control, but the dose, treatment duration, and need for gradual withdrawal depend on the condition and the individual. This guide explains how prednisolone works, how it is generally used, and which safety issues matter most.

Prednisolone overview

Each tablet contains prednisolone as the active ingredient. The oral tablets we list are available in 5 mg, 10 mg, 20 mg, and 40 mg strengths. Prednisolone belongs to the glucocorticoid group of corticosteroids and is chemically related to cortisol, a hormone produced by the adrenal glands.

Because oral prednisolone circulates throughout the body, it can treat inflammation affecting more than one tissue or organ. That systemic action is useful when local treatment is insufficient, but it also accounts for the medicine's wide range of possible adverse effects. The balance between benefit and risk changes with the dose, length of treatment, underlying illness, and other medicines being used.

How prednisolone works

Prednisolone enters cells and binds to glucocorticoid receptors. The resulting complex changes the production of proteins involved in inflammation and immune activity. This reduces inflammatory chemical signals, limits the movement and activity of certain white blood cells, and decreases swelling and leakage from small blood vessels.

These effects can relieve inflammation, but they can also weaken immune responses, alter blood glucose, affect mood and sleep, and influence bone, muscle, skin, blood pressure, and fluid balance. Prednisolone therefore treats inflammation rather than the original cause of every condition for which it is prescribed.

Established uses

Oral prednisolone may be prescribed for corticosteroid-responsive conditions such as:

• acute worsening of asthma or another inflammatory airway disorder;
• severe allergic inflammation, usually as part of a broader treatment plan;
• inflammatory or autoimmune joint and connective-tissue disorders;
• selected inflammatory skin conditions;
• inflammatory bowel disease and certain other gastrointestinal disorders;
• some blood, kidney, eye, neurological, and endocrine conditions; and
• immune suppression in selected clinical circumstances.

The exact role varies considerably. For example, an oral corticosteroid may be used briefly during an asthma flare while inhaled maintenance treatment continues. In anaphylaxis, epinephrine is the essential first-line emergency treatment; prednisolone must not be used as a substitute because its effect is not immediate. For chronic inflammatory disease, prescribers often try to minimize systemic corticosteroid exposure by using other maintenance treatments when appropriate.

Evidence and expected response

Systemic corticosteroids have a well-established anti-inflammatory effect and have been used in clinical medicine for decades. Prednisolone is included in treatment guidance for numerous corticosteroid-responsive conditions, but expected benefit and speed of response depend on the diagnosis. Some acute inflammatory symptoms may begin to improve within hours or days, while treatment of a chronic autoimmune condition may require a longer plan and additional medicines.

A lack of improvement, worsening symptoms, or repeated need for short courses should be assessed rather than managed by increasing the dose without advice. Prednisolone controls inflammation; it does not cure every underlying disease or replace condition-specific treatment.

Strengths, formulation, and general dosing principles

Prednisolone tablets are taken orally. The availability of 5 mg, 10 mg, 20 mg, and 40 mg strengths allows a prescribed total dose to be assembled and adjusted, but a tablet strength does not have one fixed clinical purpose. The appropriate dose depends on the indication, severity, age, body weight when relevant, other health conditions, treatment duration, and response.

General principles include using the lowest effective dose for the shortest appropriate period. Some conditions are treated with a brief course, while others require longer treatment and careful adjustment. A once-daily morning dose is often used when suitable because it more closely follows the body's natural cortisol rhythm, although divided dosing may be prescribed in some circumstances. Taking a dose with food may reduce stomach upset.

Children commonly receive weight- or body-surface-area-based regimens and require clinical supervision. Older adults may need closer monitoring because complications such as osteoporosis, diabetes, high blood pressure, infection, and muscle weakness can have greater consequences. Liver disease can alter prednisolone handling, while kidney disease and fluid-balance problems may also affect monitoring decisions.

Do not change the dose, combine tablets to create a different regimen, or begin a taper without instructions from the prescriber. After prolonged treatment, repeated courses, or sufficiently high doses, the adrenal glands may reduce their natural corticosteroid production. Stopping suddenly can then cause withdrawal symptoms or adrenal insufficiency. A prescriber determines whether gradual reduction is necessary and how quickly it should occur.

Elimination and half-life

Prednisolone is generally absorbed well after an oral dose, with peak blood concentrations commonly reached within about one to two hours. It is metabolized mainly in the liver and has a plasma half-life of approximately two to four hours in many adults. Its biological anti-inflammatory effects last longer, commonly about 18 to 36 hours, because changes in cell activity continue after blood concentrations decline.

These figures are general estimates rather than a dosing schedule. Liver function, interacting medicines, age, and illness can affect exposure and response.

Important safety information

Before treatment begins, the prescriber should know about current or recent infections, exposure to chickenpox or measles, diabetes, high blood pressure, heart or kidney problems, stomach ulcers, osteoporosis, glaucoma, cataracts, seizures, blood-clotting problems, and a history of significant mood or psychiatric symptoms. Recent and planned vaccinations should also be discussed.

Systemic corticosteroids can hide signs of infection while making some infections more severe. Prompt medical advice is important if fever, persistent sore throat, unusual weakness, a wound that is not healing, or another possible sign of infection develops. People receiving immunosuppressive doses should seek urgent advice after exposure to chickenpox or measles if they are not known to be immune.

Pregnancy, breastfeeding, and children

Prednisolone crosses the placenta. During pregnancy, it is used when a prescriber judges that the expected benefit outweighs potential fetal risk. Untreated maternal inflammatory disease may also carry risks, so treatment should not be stopped abruptly after pregnancy is discovered.

Small amounts of prednisolone pass into breast milk. Daily doses up to 40 mg are generally not expected to produce systemic effects in a breastfed infant, but higher or prolonged maternal dosing may require individual advice and monitoring for possible adrenal suppression.

Prednisolone has established paediatric uses, but prolonged systemic treatment can slow growth and affect bone development. Children should receive the lowest effective dose, with growth and other adverse effects monitored during longer treatment.

Driving and daily activities

Prednisolone does not impair everyone, but dizziness, vertigo, blurred vision, fatigue, insomnia, confusion, agitation, or other mood changes can occur. Do not drive or operate machinery if these effects interfere with alertness or vision.

Contraindications and situations requiring caution

• Hypersensitivity: Do not take a tablet after a known serious reaction to prednisolone or one of its ingredients.
• Systemic fungal infection: Systemic corticosteroid treatment is generally contraindicated unless specialist management specifically requires it.
• Other untreated infections: Bacterial, viral, parasitic, or localized fungal infections may worsen when immune activity is suppressed.
• Live vaccines: Live vaccines may be contraindicated during immunosuppressive corticosteroid treatment. Vaccine type, dose, and timing must be reviewed with a health professional.
• Diabetes: Prednisolone can raise blood glucose and may increase insulin or oral diabetes medicine requirements.
• Peptic ulcer or gastrointestinal bleeding: Risk may be higher when prednisolone is combined with non-steroidal anti-inflammatory drugs or other medicines that affect the stomach or bleeding.
• Osteoporosis: Longer systemic treatment accelerates bone loss and may increase fracture risk.
• Eye disorders: Corticosteroids can contribute to cataracts, increased eye pressure, glaucoma, or certain eye infections.
• Mood and psychiatric disorders: Euphoria, anxiety, depression, agitation, confusion, or psychotic symptoms can occur, sometimes soon after treatment begins or the dose changes.

Medicine and vaccine interactions

Prednisolone has clinically important interactions. A prescriber or pharmacist should review prescription medicines, non-prescription products, and supplements before treatment starts.

• Non-steroidal anti-inflammatory drugs, including ibuprofen and naproxen, may increase gastrointestinal irritation, ulceration, or bleeding.
• Anticoagulants, such as warfarin, may require closer monitoring because the anticoagulant effect can change.
• Diabetes medicines may become less effective as blood glucose rises.
• Potassium-depleting diuretics and some other medicines can increase the risk of low potassium.
• Strong enzyme inducers, including rifampin, carbamazepine, phenytoin, and phenobarbital, can reduce corticosteroid exposure.
• Strong enzyme inhibitors, including some azole antifungals and certain antiviral medicines, can increase corticosteroid exposure and adverse effects.
• Vaccines may produce a weaker immune response, and live vaccines can be unsafe during immunosuppressive treatment.
• Other immunosuppressants can increase infection risk and may require additional monitoring.

Alcohol has no single predictable direct interaction with prednisolone, but it can worsen stomach irritation and may add to concerns about blood glucose, mood, sleep, or bone health. Individual advice is appropriate when these risks apply.

Side effects and what to do

Risk increases with higher doses, repeated courses, and longer treatment. Short courses can still cause indigestion, increased appetite, insomnia, fluid retention, mood changes, or higher blood glucose. Longer exposure can contribute to weight gain, high blood pressure, thinning skin, easy bruising, muscle weakness, osteoporosis, eye problems, infection, and suppression of natural adrenal function.

Contact a health professional if an adverse effect is persistent, worsening, or difficult to manage. Seek urgent medical care for a serious allergic reaction, severe infection symptoms, major vision changes, black or bloody stools, vomiting blood, severe abdominal pain, extreme weakness or fainting, or marked behavioural or psychiatric changes. Do not stop ongoing prednisolone treatment abruptly in response to a side effect unless emergency clinicians direct you to do so.

Overdose and dosing errors

Taking more prednisolone than prescribed can increase blood glucose, blood pressure, fluid retention, agitation, insomnia, stomach irritation, electrolyte disturbances, and infection risk. Harm depends on the amount, whether excessive doses were repeated, the person's age and health, and other medicines taken. A single dosing error should not be dismissed without checking the circumstances.

If too much was taken, contact a poison control centre or health professional promptly for case-specific advice. Seek emergency help immediately for collapse, breathing difficulty, a seizure, severe confusion, or another serious symptom. Keep the package available so the tablet strength, possible quantity, and time of ingestion can be identified. Do not induce vomiting unless a health professional specifically instructs you to do so.

Storage and disposal

Store prednisolone tablets at 20°C to 25°C in a tightly closed container, protected from moisture, heat, and light. Keep them out of the sight and reach of children, and do not use tablets after the expiry date on the package. Return unused or expired medicine to a pharmacy for safe disposal rather than flushing it or placing it in household waste.

Prescription status and our ordering policy

Systemic oral prednisolone is a prescription drug in Canada and normally requires authorization from an authorized prescriber. That regulatory classification is separate from our ordering policy. We do not require customers to submit a prescription through our checkout before we accept an order for this product; this does not change prednisolone's Canadian prescription status or replace an appropriate medical assessment.

We list oral prednisolone tablets in 5 mg, 10 mg, 20 mg, and 40 mg strengths, with the currently offered quantities shown on the product page. Our support team is available by email and online chat 24/7, and pharmacist support is available for questions about the medicine, our listed options, or our ordering process. Our team cannot determine an individualized dose or taper without the clinical information and prescribing authority required for that decision.

Health Canada's Drug Product Database is the official public source for checking the DIN, strength, dosage form, manufacturer, and market status of a specific Canadian product. Suspected adverse reactions can be reported to Health Canada through the Canada Vigilance Program.

Benefits and trade-offs

Prednisolone's main benefit is a broad and often rapid anti-inflammatory effect. Oral tablets are convenient when treatment must reach several areas of the body or when local therapy is insufficient. Multiple strengths also allow a prescriber to adjust the total dose and, when necessary, plan a gradual reduction.

The principal trade-off is that systemic exposure can affect many organs. A short course may cause temporary sleep, appetite, mood, stomach, or glucose changes, while longer treatment raises concerns such as infection, osteoporosis, cataracts, muscle weakness, skin changes, and adrenal suppression. Prednisolone is therefore not universally preferable to a local or non-steroid treatment. Its value depends on whether the expected control of inflammation outweighs these risks.

Generic equivalents and similar medicines

A generic equivalent contains the same active ingredient, prednisolone, in the same strength and dosage form, although inactive ingredients and tablet appearance may differ. The package information should be checked when an excipient allergy or intolerance is relevant.

Other corticosteroids are therapeutic alternatives rather than generic equivalents:

• Prednisone is converted by the liver to prednisolone and is used for many similar indications. The two medicines are not identical products and should not be substituted milligram for milligram without professional direction.
• Methylprednisolone is somewhat more potent per milligram and, like prednisolone, is generally considered intermediate-acting.
• Dexamethasone is substantially more potent per milligram and longer-acting, with relatively little mineralocorticoid activity.
• Hydrocortisone is shorter-acting and has greater mineralocorticoid activity relative to its anti-inflammatory potency.
• Inhaled corticosteroids, such as budesonide, can treat airway inflammation with less systemic exposure than oral treatment, although some absorption still occurs.
• Topical corticosteroids may be preferable for suitable skin conditions because they act mainly at the application site.

Potency, duration, route, and condition-specific evidence all matter when choosing among these treatments. Changing from one corticosteroid to another requires dose conversion and clinical judgement; it is not simply a matter of selecting the tablet with the highest milligram strength.